Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Medivir appoints Dr. Tom Morris as interim Chief Medical Officer PR Newswire STOCKHOLM, Oct. 5, 2020 STOCKHOLM, Oct. 5, 2020 /PRNewswire/...
The European Commission has Granted Orphan Medicinal Product Designation in the EU for MIV-818 PR Newswire STOCKHOLM, July 3, 2020 STOCKHOLM...
FDA Grants MIV-818 Orphan Drug Designation for the Treatment of Hepatocellular Carcinoma PR Newswire STOCKHOLM, May 6, 2020 STOCKHOLM, May 6...
Medivir AB - Interim Report January - March 2020 PR Newswire HUDDINGE, Sweden, May 5, 2020 HUDDINGE, Sweden, May 5, 2020 /PRNewswire/ -- ...
Medivir Receives Positive Opinion on Orphan Medicinal Drug Designation by the European Medicines Agency for MIV-818 PR Newswire STOCKHOLM, April...
Notice of Annual General Meeting of Medivir AB (publ) PR Newswire HUDDINGE, Sweden, April 6, 2020 HUDDINGE, Sweden, April 6, 2020 /PRNewswire/...
Medivir and Tango Therapeutics Sign License Agreement for Preclinical Asset PR Newswire STOCKHOLM, March 16, 2020 STOCKHOLM, March 16, 2020...
First Liver Cancer Patient Dosed in the MIV-818 Phase Ib Study PR Newswire STOCKHOLM, March 10, 2020 STOCKHOLM, March 10, 2020 /PRNewswire/...
Invitation to Medivir's R&D Day on March 2, 2020 PR Newswire STOCKHOLM, Feb. 25, 2020 STOCKHOLM, Feb. 25, 2020 /PRNewswire/ -- Medivir AB...
Medivir AB: Year End Report January-December 2019 Continued progress with proprietary and wholly owned candidate drug MIV-818 for liver cancer PR...
Medivir Invites to R&D Day on March 2, 2020 PR Newswire STOCKHOLM, Feb. 11, 2020 STOCKHOLM, Feb. 11, 2020 /PRNewswire/ -- Medivir AB (Nasdaq...
Medivir's Phase II Study of MIV-711 in Patients With Osteoarthritis Published in Annals of Internal Medicine PR Newswire STOCKHOLM, Jan. 20, 2020...
Investigator-initiated Phase II Clinical Study of Remetinostat Started in Patients With Squamous Cell Carcinoma PR Newswire STOCKHOLM, Dec. 18...
Medivir Reports Last Patient Recruited to the Phase Ia Study of MIV-818 in Liver Cancer Patients and Initial Dose Determined for phase Ib PR...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지